top of page
Couple
Rediscover Intimacy – Naturally  
Shockwave Therapy for Erectile Dysfunction

Erectile Dysfunction (ED) is a global problem.

Welcome to ED-Information. Take the first step towards regaining natural performance and confidence today.

320 Million

men³ are estimated to suffer from ED

52%

of men between the ages of 40 and 70 experience some degree of ED

48%

risk of side effects with PDE5i pills (popular brands: Viagra, Cialis, etc.)

20%

of all relationship breakups are caused by persistent ED

Discover If ED Is Affecting You – Quick, Free Assessment

The IIEF-5 Questionnaire (International Index of Erectile Function) can provide indications of whether a medical issue related to erectile dysfunction may be present.

TREATMENT METHODS

MEDICATION-BASED TREATMENTS


Well-known therapies such as PDE5 inhibitors, apomorphine or impotence injections are often associated with side effects.

NON-MEDICATION-BASED TREATMENTS

Compared to more invasive methods such as penile prosthesis implantation or the use of a vacuum erection device, low-intensity shockwave therapy is a non-invasive treatment option that is generally well tolerated.

NATURAL ED RELIEF WITH
INNOVATIVE SHOCKWAVE THERAPY

Low-intensity extracorporeal shockwave therapy (LI-ESWT) represents an innovative and proven method for treating erectile dysfunction, as measured¹⁴ by International Index of Erectile Function (IIEF) and Erection Hardness Score (EHS). This therapy leads to a significant improvement in erectile function, enabling patients to regain sexual spontaneity, which in turn restores their overall quality of life. The effectiveness of shockwave therapy is based on addressing the primary cause of erectile dysfunction: reduced blood flow to the penile tissue.

SIMPLE

TREATMENT

Shockwave therapy is a gentle and effective treatment option for patients with urogenital conditions.

NON-

INVASIVE

Shockwave therapy is generally pain-free and requires no anesthesia. To date, no significant side effects have been observed.

SCIENTFICALLY

SUPPORTED

The effectiveness of shockwave therapy has been demonstrated in numerous clinical studies. These studies¹⁵ show that improvement in erectile function can last for at least two years after treatment.

RESTORES

NATURAL ERECTIONS

By stimulating the body’s own production of growth factors and promoting the formation of new blood vessels, shockwaves facilitate the development of natural erection.

WHAT ARE SHOCKWAVES?

Shockwaves¹⁶ are acoustic waves with an extremely rapid rise time of a few nanoseconds, characterized by a pulse of positive pressure followed by a phase of negative pressure.

Shockwaves have been used for over two decades to improve blood circulation and support tissue regeneration across multiple clinical domains¹⁷, such as urology, orthopedics, sports medicine, aesthetics and wound care.

HOW DO THE TREATMENT WORKS?

And how effective are they?

Shockwave therapy harnesses the biological effects¹⁷ of acoustic waves to stimulate the body’s natural healing processes at both the cellular and vascular levels. It promotes the formation of new blood vessels (neovascularization), enhances local blood flow and triggers the release of angiogenic growth factors such as VEGF. Preclinical and clinical studies also indicate that shockwaves may stimulate the migration of stem cells to the treated area, further supporting tissue regeneration and vascular repair.

These combined effects contribute to a sustained improvement¹⁸ in erectile function by targeting one of the primary causes of erectile dysfunction: reduced penile blood flow. As a result, many patients report the restoration of sexual spontaneity and a significant improvement in quality of life.

Shockwave therapy is considered a safe¹⁹ and well-tolerated treatment option, particularly for patients who do not respond to phosphodiesterase-5 inhibitors (e.g., sildenafil). It is performed on an outpatient basis, does not require anesthesia, and is typically described as pain-free. To date²⁰, no serious adverse effects have been reported in clinical studies.

HOW IS THE
DEVICE DESIGNED?

Currently, there are several companies worldwide offering shockwave therapy systems. The key difference lies in their medical effectiveness and how thoroughly their technical development has been evaluated through scientific research.

With the urogold100 therapy system, MTS Medical provides a clinically tested, non-invasive LI-ESWT treatment option for erectile dysfunction (ED) and other urogenital conditions that are both safe and designed for long-term effectiveness.

MTS Medical Spark Wave urogold100 Device
HAVE QUESTIONS ABOUT
SHOCKWAVE TREATMENT?

Click on any question below to learn more.

SHOCKWAVE THERAPY EXPLANED:
EXPERT OPINIONS ON SPARK WAVE

Dipl. med. Klaus Weißflog

Urologist - Germany

“Treatment with the urogold100 is pain-free for my patients and takes only a few minutes to complete. It’s a true alternative to conventional ED treatment options—without side effects.”

Dr. Irwin Goldstein 

Urologist - USA

“I have successfully treated over 3,000 patients. There are simply so many possible applications for this device.”

 


References 
 

  1. European Association of Urology. (2022). Management of Erectile Dysfunction. In Sexual and Reproductive Health Guidelines (Chapter 5). Uroweb. Retrieved August 5, 2025, from https://uroweb.org/guidelines/sexual-and-reproductive-health-2022/chapter/management-of-erectile-dysfunction

  2. Kouidrat, Y., Pizzol, D., Cosco, T., Thompson, T., Carnaghi, M., Bertoldo, A., Solmi, M., Stubbs, B., & Veronese, N. (2017). High prevalence of erectile dysfunction in diabetes: A systematic review and meta‑analysis of 145 studies. Diabetic Medicine, 34(9), 1185–1192. https://doi.org/10.1111/dme.13403

  3. Leslie, S. W., & Sooriyamoorthy, T. (2024, January 9). Erectile dysfunction. In StatPearls [Internet]. StatPearls Publishing. Treasure Island, FL. Retrieved August 5, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK562253/

  4. Kessler, A. (2019). The global prevalence of erectile dysfunction: A review. BJU International, 124(4), 587–599. https://doi.org/10.1111/bju.14813

  5. Lui, J. L., Shaw, N. M., Abbasi, B., Hakam, N., & Breyer, B. N. (2023). Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database. Andrology, 11(7), 1408–1417. https://doi.org/10.1111/andr.13430

  6. Zenoozian, S., Bayat, F., Soltani, A., Mirloo, M. M., & Kharaghani, R. (2024). The prevalence of sexual problems in the divorced population and the prevalence of separation in populations with sexual problems: A meta‑analysis. International Journal of Impotence Research, 37, 347–355. https://doi.org/10.1038/s41443-024-00918-2

  7. Brock, G. (2002). Oral agents: first‑line therapy for erectile dysfunction. European Urology Supplements, 1(4), 30–35.

  8. Pyrgidis, N., Kalyvianakis, D., Mykoniatis, I., & Hatzichristou, D. (2024, August 6). The recommended treatment protocol for low‑intensity shockwave therapy based on the severity of erectile dysfunction. International Journal of Impotence Research, 37, 566–568. https://doi.org/10.1038/s41443‑024‑00959‑7

  9. National Institute of Diabetes and Digestive and Kidney Diseases. (2024). Treatment for erectile dysfunction. In Health Information | Urologic Diseases | Erectile Dysfunction. National Institutes of Health. Retrieved August 5, 2025, from https://www.niddk.nih.gov/health-information/urologic-diseases/erectile-dysfunction/treatment

  10. Cleveland Clinic. (2025). Apomorphine (Apokyn) injection: uses & side effects. In Health Library – Drugs, Devices & Supplements. Retrieved August 5, 2025, from https://my.clevelandclinic.org/health/drugs/19850-apomorphine-injection

  11. National Institute of Diabetes and Digestive and Kidney Diseases. (2024, October). Treatment for erectile dysfunction. In Health Information: Urologic Diseases → Erectile Dysfunction. National Institutes of Health. Retrieved August 5, 2025, from https://www.niddk.nih.gov/health‑information/urologic‑diseases/erectile‑dysfunction/treatment

  12. Cavayero, C. T., Leslie, S. W., & McIntosh, G. V. (2025, January). Penile prosthesis implantation. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. Retrieved August 5, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK563292/

  13. Kouidrat, Y., Pizzol, D., Cosco, T., Thompson, T., Carnaghi, M., Bertoldo, A., Solmi, M., Stubbs, B., & Veronese, N. (2017). High prevalence of erectile dysfunction in diabetes: A systematic review and meta‑analysis of 145 studies. Diabetic Medicine, 34(9), 1185–1192. https://doi.org/10.1111/dme.13403

  14. Vardi, Y., Appel, B., Kilchevsky, A., & Gruenwald, I. (2012). Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short‑term results of a randomized, double‑blind, sham‑controlled study. The Journal of Urology, 187(5), 1769–1775. https://doi.org/10.1016/j.juro.2011.12.117

  15. Kitrey, N. D., Vardi, Y., Appel, B., Shechter, A., Massarwa, O., Abu‑Ghanem, Y., … Gruenwald, I. (2018). Low‑intensity shock wave treatment for erectile dysfunction: How long does the effect last? Two‑year follow‑up of a randomized sham‑controlled study. The Journal of Urology, 200(1), 167–170. https://doi.org/10.1016/j.juro.2018.02.070

  16. De la Corte‑Rodríguez, H., Román‑Belmonte, J. M., Rodríguez‑Damiani, B. A., Vázquez‑Sasot, A., & Rodríguez‑Merchán, E. C. (2023). Extracorporeal shock wave therapy for the treatment of musculoskeletal pain: A narrative review. Healthcare, 11(21), 2830. https://doi.org/10.3390/healthcare11212830

  17. Crevenna, R., Mickel, M., Schuhfried, O., Gesslbauer, C., Zdravkovic, A., & Keilani, M. (2021). Focused extracorporeal shockwave therapy in physical medicine and rehabilitation. Current Physical Medicine and Rehabilitation Reports, 9(1), 1–10. https://doi.org/10.1007/s40141-020-00306-z

  18. Gruenwald, I., Appel, B., Kitrey, N. D., & Vardi, Y. (2013). Shockwave treatment of erectile dysfunction. Therapeutic Advances in Urology, 5(2), 95–99. https://doi.org/10.1177/1756287212470696

  19. Lu, Z., Reed‑Maldonado, A., Wang, C., Lee, Y., & Lue, T. F. (2017). Low‑intensity extracorporeal shock wave treatment improves erectile function: A systematic review and meta‑analysis. European Urology, 71(2), 223–233. https://doi.org/10.1016/j.eururo.2016.05.050

  20. Clavijo, R. I., Kohn, T. P., Kohn, J. R., Ramasamy, R., & Chung, E. (2017). Effects of low‑intensity extracorporeal shock wave therapy on erectile dysfunction: a randomized sham‑controlled trial. The Journal of Sexual Medicine, 14(1), 27–35. https://doi.org/10.1016/j.jsxm.2016.11.001

bottom of page